- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Theranostic Trial Evaluating the Effects of Thiethylperazine in Patients Diagnosed with an Early Stage of Alzheimer's disease
This study is looking into a new treatment for early Alzheimer's disease. It's testing if a medicine called thiethylperazine can slow down changes in the brain linked to Alzheimer's, using special brain scans and blood tests.
For: Newly diagnosed early-to-mild dementia due to Alzheimer's DiseaseGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight with Comorbidity
This study is looking at a new combination of medicines (AZD9550 and AZD6234) for people who are overweight or have obesity and other health problems. Researchers want to see if these medicines help with weight loss and if they are safe to use.
For: Investigating obesity or overweight condition correlated to many co-morbiditiesGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Versus EU-Prolia® in Women with Post- Menopausal Osteoporosis
This study compares a new medicine (BP16) with an existing one (Prolia®) for women with weak bones after menopause. Researchers will check if BP16 helps strengthen bones, how safe it is, and if the body reacts to it, over about a year and a half.
For: Post-Menopausal OsteoporosisLatvia · Estonia · Slovakia